In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis

Thorax

Volumn 51, Issue 2, 1996, Pages 119-125

  Shah, Pallav L ^a   Scott, Sandra F ^a   Knight, Richard A ^a   Marriott, Christopher ^b   Ranasinha, Channa ^a   Hodson, Margaret E ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cystic fibrosis; DNA content; RhDNase; Sputum; Theology

Indexed keywords

DEOXYRIBONUCLEASE; DNA; PLACEBO;

ARTICLE; BLOOD RHEOLOGY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM;

EID: 0030027655     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.2.119     Document Type: Article

References (32)

1. Penketh AR, Wise A, Mearns MB, Hodson ME, Batten JC. Cystic fibrosis in adolescents and adults. Thorax 1987;42: 526-32.
2. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:i-9.
3. Lethem MI, James SL, Marriott C, Burke JF. The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur Respir J 1990;3:19-23.
4. Chernick WS, Barbero GJ. Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis. Pediatrics 1959;24:739-45.
5. Potter J, Matthews LW, Lemm J, Spector JS. Composition of pulmonary secretions from patients with and without cystic fibrosis. Am J Dis Child 1960;100:493-5.
6. Lethem MI, James SL, Marriott C. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum. Am Rev Respir Dis 1990;142:1053-58.
7. King M. Mucus, mucociliary clearance and coughing. In: Bates DV, ed. Respiratory function in disease. 3rd edn. Philadelphia: Saunders 1989:Chapter 3.
8. Hodson ME, Warner JO. Cystic fibrosis: respiratory problems and their management. Br Med Bull 1992;48:931-48.
9. Stafanger G, Garne S, Howitz P, Morkassel E, Koch C. The clinical effect and the effect on the ciliary motility of oral N-acetylcysteine in patients with cystic fibrosis and primary ciliary dyskinesia. Eur Respir J 1988;1:161-7.
10. Stafanger G, Koch C. N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility. Eur Respir J 1989;2:234-7.
11. Ratjen F, Wonne R, Posselt HG, Stover B, Hofmann D, Bender SW. A double blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis. Eur J Pediatr 1985;144:374-8.
12. Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990;87: 9188-92.
13. Aitken ML, Burke W, McDonald G, Shak S, Montgomery AB, Smith A. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase I study. J Am Med Assoc 1992;267:1947-51.
14. Hubbard RC, McElvaney NG, Birrer P, Shak S, Robinson WW, Jolley C, et al. A preliminary study of aerosolised recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med 1992;326:812-5.
15. Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, et al. Efficacy and safety of short-term administration of aerosolised recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis 1993;148:145-51.
16. Ranasinha C, Assoufi B, Shak S, Christiansen D, Fuchs H, Empey D, et al. Efficacy and safety of short-tern administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis. Lancet 1993; 342:199-202.
17. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, et al. Effect of aerosolised recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994;331:637-42.
18. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilising pilocarpine by iontophoresis. Pediatrics 1959;23:545-9.
19. American Thoracic Society. Standardisation of spirometry - 1987 update. Am Rev Respir Dis 1987;136:1285-98.
20. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and ageing. Am Rev Respir Dis 1983; 127:725-34.
21. King M, Brock G, Lundell C. Clearance of mucus by stimulated cough. J Appl Physiol 1985;58:1776-82.
22. King M. Role of mucus viscoelasticity in cough clearance. Biorheology 1987;24:589-97.
23. Laube BL, Auci RM, Shields DE, Christiansen D, Fuchs HJ, Rosenstein BJ. A randomised, placebo controlled trial of the effect of recombinant human DNase I (rhDNase) on the deposition homogeneity and mucociliary clearance of radioaerosol in patients with cystic fibrosis. Pediatr Pulmonol 1983;Suppl 9:155-6.
24. Puchelle E, Zahm JM, Polu JM, Sadoul P. Drug effects on viscoelasticity of mucus. Eur J Respir Dis 1980;61(Suppl 110):195-208.
25. Shih CK, Litt M, Khan MA, Wolf DP. Effect of nondialyzable solids concentration and viscoelasticity on ciliary transport of tracheal mucus. Am Rev Respir Dis 1977; 115:989-95.
26. King M, Gilboa A, Meyer FA, Silberberg A. On the transport of mucus and its rheologic stimulants in ciliated systems. Am Rev Respir Dis 1974;110:740-5.
27. Dulfano MJ, Adler KB. Physical properties of sputum. VII. Rheologie properties and mucociliary transport. Am Rev Respir Dis 1975;112:341-7.
28. Shah PL, Scott SF, Marriott C, Knight RA, Hodson ME. A comparison of the rheological and inflammatory activity of cystic fibrosis and bronchiectasis sputum. Eur Respir J 1994;4(Suppl 18):79s (abstract).
29. Vasconcellos CA, Allen PG, Wohl ME, Drazen JM, Janmey PA, Stössel TP. Reduction in viscosity of cystic fibrosis sputum in vitro by Gelsolin. Science 1994;263:969-71.
30. Hitchcock SE, Carisson L, Lindberg U. Depolymerisation of F-actin by deoxyribonuclease I. Cell 1976;7:531-42.
31. Lazarides E, Lindberg U. Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc Natl Acad Sci USA 1974;71:4742-6.
32. Shah PL, Scott SF, Knight RA, Hodson ME. The effects of recombinant human DNase I on neutrophil elastase activity and interleukin-8 levels. Eur Respir J 1995 (in press).